Results 41 to 50 of about 449 (133)

Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer. [PDF]

J Transl Med, 2023
Seok J, Kwak HJ, Kwak Y, Lee M, Park KS, Kim A, Cho SG.   +6 more
europepmc   +1 more source

Design, Synthesis, and Evaluation of a Luminescent Cholesterol Mimic. [PDF]

J Org Chem, 2021
Work EM, Ferraudi G, Kiefer L, Liu G, Grigalunas M, Bhardwaj A, Kaur R, Dempsey JM, Wüstner D, Helquist P, Wiest O.   +10 more
europepmc   +1 more source

5-alpha reductase inhibitors use in prostatic disease and beyond. [PDF]

Transl Androl Urol, 2023
Chislett B, Chen D, Perera ML, Chung E, Bolton D, Qu LG.   +5 more
europepmc   +1 more source

Azasteroide. III

YAKUGAKU ZASSHI, 1958
openaire   +2 more sources

Mce3R Stress-Resistance Pathway Is Vulnerable to Small-Molecule Targeting That Improves Tuberculosis Drug Activities. [PDF]

ACS Infect Dis, 2019
Yang X, Yuan T, Ma R, Chacko KI, Smith M, Deikus G, Sebra R, Kasarskis A, van Bakel H, Franzblau SG, Sampson NS.   +10 more
europepmc   +1 more source

Discovery and development of steroidal enzyme inhibitors as anti-cancer drugs: state-of-the-art and future perspectives. [PDF]

J Enzyme Inhib Med Chem
Cerra B, Gioiello A.
europepmc   +1 more source

Azasteroid. IV

YAKUGAKU ZASSHI, 1958
openaire   +2 more sources

Ring Expansions of 1,2-Amino Alcohols to Amine Heterocycles Enabled by Proton-Coupled Electron Transfer. [PDF]

J Am Chem Soc
Thach DQ, Knowles RR.
europepmc   +1 more source

Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives. [PDF]

Oxid Med Cell Longev, 2022
Semwal P, Painuli S, Abu-Izneid T, Rauf A, Sharma A, Daştan SD, Kumar M, Alshehri MM, Taheri Y, Das R, Mitra S, Emran TB, Sharifi-Rad J, Calina D, Cho WC.   +14 more
europepmc   +1 more source

Steroid 5α-reductases in the brain: From neurosteroidogenesis to therapeutic implications. [PDF]

Front Neuroendocrinol
Braccagni G, Branca C, Bortolato M.
europepmc   +1 more source